NCT06014554 Structured Tailored Rehabilitation After Hip Fragility Fracture
| NCT ID | NCT06014554 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King's College London |
| Condition | Hip Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-04-15 |
| Primary Completion | 2025-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-04-15 with a primary completion date of 2025-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Why the investigators are doing this study? The best approach to rehabilitation after a broken hip is not known. A new approach could improve outcomes by tailoring rehabilitation to patient needs. This approach identifies subgroups of patients within a population who have different risks of poor outcomes. These subgroups are then matched to treatments better tailored to their needs. Survivors of a broken hip describe a tailored approach as key to recovery. Further, the NHS recommends this approach as central to healthcare progress. This study wants to see if it is possible for the NHS to deliver this new approach to rehabilitation for older adults who break their hip. What will be done? The investigators worked with patients to plan this study. Patients will keep helping the investigators during the study. Sixty older people who had surgery to fix a broken hip will be invited to take part. Participants will be given a level of risk (low, medium, or high) based on an online calculator (www.stratifyhip.co.uk). All 60 participants will get usual care provided locally. Half, selected by chance, will get extra rehabilitation during their hospital stay including a self-managed exercise programme for the low-risk subgroup, education, a goal-orientated mobility programme and enhanced discharge planning for the medium-risk subgroup, and education, a goal-orientated activity of daily living programme, orientation, and enhanced assessment for the high-risk subgroup. The investigators will collect information from the 60 people taking part, at the beginning, middle, and end of the study and again 12- weeks later. What will the next step be? If this small study shows this extra rehabilitation can be provided in the NHS, and it may help patients, then the investigators plan to do a larger study. The larger study will see if this extra rehabilitation works to help older people get back home and feel happier.
Eligibility Criteria
Inclusion Criteria: We will include adults * aged 60 years or more. * admitted to hospital for surgical repair of a hip fracture. * who are willing and able to provide consent or assent depending on the level of cognitive impairment. Exclusion Criteria: We will exclude adults * less than 60 years, to align with the National Hip Fracture Databases definition of the target population. * not surgically treated, as this treatment approach is reserved for around 2% of patients in the UK who are often at the end of life. * who broke their hip in hospital following admission for a different illness/injury as their anticipated care pathway and outcomes will vary from those who are admitted for hip fracture. * participating in other treatment trials and without agreement of both trial teams.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06014554 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Hip Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06014554 currently recruiting?
Yes, NCT06014554 is actively recruiting participants. Contact the research team at katie.sheehan@kcl.ac.uk for enrollment information.
Where is the NCT06014554 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06014554 clinical trial?
NCT06014554 is sponsored by King's College London. The trial plans to enroll 60 participants.